Select Medical Stock Intrinsic Value – SELECT MEDICAL Reports Record Revenue and Income for Q2 of Fiscal Year 2023
August 6, 2023
🌥️Earnings Overview
SELECT ($NYSE:SEM): For the second quarter of fiscal year 2023 (ending on June 30 2023), MEDICAL reported total revenue of USD 1674.5 million and net income of USD 78.2 million, showing a 5.7% and 41.7% increase respectively compared to the same quarter of the previous year.
Share Price
The company opened at $30.2 and closed at $30.4, a slight increase of 0.3% from the previous closing price of 30.4. This marks the third consecutive quarter of growth for SELECT MEDICAL, as the company continues to expand its operations and bring in increasing revenue. The news of the record revenue and income came as a positive surprise for investors, who have seen their stock prices rise steadily over the past few quarters. With SELECT MEDICAL making significant investments into new technology and innovations, the company is well-positioned for further growth over the next year.
Going forward, SELECT MEDICAL is expected to continue to deliver strong financial performance. As the company continues to invest in innovative technology and services, it is likely that the stock will remain strong and that revenue and income will continue to increase in the coming quarters. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Select Medical. More…
| Total Revenues | Net Income | Net Margin |
| 6.49k | 196.21 | 3.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Select Medical. More…
| Operations | Investing | Financing |
| 393.08 | -248.12 | -138.47 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Select Medical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 7.7k | 6.17k | 9.78 |
Key Ratios Snapshot
Some of the financial key ratios for Select Medical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 6.2% | 0.4% | 8.1% |
| FCF Margin | ROE | ROA |
| 2.7% | 27.0% | 4.2% |
Analysis – Select Medical Stock Intrinsic Value
After conducting an analysis of SELECT MEDICAL‘s financials, GoodWhale has concluded that the fair value of SELECT MEDICAL’s share is around $31.2. This valuation was determined using our proprietary Valuation Line. Right now, SELECT MEDICAL stock is traded at $30.4, which is a fair price, albeit slightly undervalued by 2.7%. More…
Peers
The company’s competitors include Eukedos SpA, Med Life SA, Athens Medical Centre SA, and other similar companies.
– Eukedos SpA ($LTS:0Q8E)
Eukedos SpA is a pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of rare diseases. The company has a market cap of 28.09M as of 2022 and a Return on Equity of 10.29%. Eukedos SpA is headquartered in Milan, Italy.
– Med Life SA ($LTS:0RO5)
MedLife SA is a publicly traded company with a market capitalization of 2B as of 2022. The company’s return on equity is 22.48%. MedLife SA is a leading provider of medical and healthcare services in South America. The company offers a full range of services including primary care, hospital care, specialty care, and behavioral health services. MedLife SA also has a strong presence in the insurance and managed care markets.
– Athens Medical Centre SA ($LTS:0ONM)
Athens Medical Centre SA is a medical company that operates in Greece. The company has a market cap of 117.53M as of 2022 and a return on equity of 18.02%. The company provides medical services and products to patients in Greece. Athens Medical Centre SA operates in the following segments: Medical Services, Medical Products, and Other. The Medical Services segment provides medical services to patients in Greece. The Medical Products segment provides medical products to patients in Greece. The Other segment includes activities such as real estate and investments.
Summary
Investors appear to be optimistic regarding SELECT MEDICAL‘s performance in the second quarter of fiscal year 2023. Reported total revenue increased by 5.7%, and net income rose by an impressive 41.7% compared to the same quarter of the previous year. This signals a strong positive trend for the company, suggesting that SELECT MEDICAL is a viable investment opportunity. The figures for the second quarter indicate that the company is continuing its successful growth trajectory and could prove to be a lucrative investment in the future.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
